Simplex Trading’s INmune Bio INMB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.75K Buy
4,200
+3,600
+600% +$5.13K ﹤0.01% 7925
2025
Q4
$936 Sell
600
-45,100
-99% -$80.5K ﹤0.01% 8039
2025
Q3
$94K Sell
45,700
-26,000
-36% -$59.5K ﹤0.01% 5817
2025
Q2
$165K Buy
71,700
+46,100
+180% +$338K ﹤0.01% 4711
2025
Q1
$199K Sell
25,600
-57,600
-69% -$457K ﹤0.01% 4335
2024
Q4
$388K Buy
83,200
+9,600
+13% +$50K ﹤0.01% 3807
2024
Q3
$396K Buy
73,600
+67,800
+1,169% +$482K ﹤0.01% 3848
2024
Q2
$51K Sell
5,800
-900
-13% -$8.87K ﹤0.01% 6061
2024
Q1
$78K Buy
6,700
+4,100
+158% +$49.5K ﹤0.01% 5846
2023
Q4
$29K Buy
2,600
+2,100
+420% +$17.6K ﹤0.01% 6593
2023
Q3
$3K Sell
500
-700
-58% -$5.8K ﹤0.01% 7904
2023
Q2
$10K Sell
1,200
-7,400
-86% -$59.4K ﹤0.01% 7405
2023
Q1
$55K Buy
8,600
+6,800
+378% +$54.8K ﹤0.01% 5820
2022
Q4
$11K Sell
1,800
-1,000
-36% -$7.1K ﹤0.01% 7454
2022
Q3
$17K Sell
2,800
-1,300
-32% -$11.4K ﹤0.01% 7683
2022
Q2
$36K Buy
4,100
+2,000
+95% +$14.9K ﹤0.01% 6916
2022
Q1
$17K Sell
2,100
-2,100
-50% -$18.9K ﹤0.01% 8405
2021
Q4
$42K Buy
4,200
+800
+24% +$11.8K ﹤0.01% 7472
2021
Q3
$62K Hold
3,400
﹤0.01% 7264
2021
Q2
$59K Buy
+3,400
New +$45.8K ﹤0.01% 7443

Other funds holding INMB

Simplex Trading's INMB Position: Q1 2026 in Review

Simplex Trading reduced its INmune Bio (INMB) stake by 58% in Q1 2026, selling an estimated $6.59K and leaving 3,366 shares worth $3.8K. The position accounts for ﹤0.01% of the portfolio, ranked #8057.

Simplex Trading first reported a position in INMB in Q2 2021 and has held it in 17 quarters since. The position peaked at $334K in Q1 2025. 82 funds tracked by Wall St. Rank hold INMB as of Q1 2026.

  • Simplex Trading held 3,366 shares of INmune Bio worth $3.8K as of Q1 2026.
  • Simplex Trading sold 4,623 INmune Bio shares in Q1 2026, an estimated $6.59K.
  • INmune Bio made up ﹤0.01% of Simplex Trading's portfolio in Q1 2026, its #8057 holding.
  • Simplex Trading first reported a position in INmune Bio in Q2 2021 and has held it in 17 quarters since.
  • Simplex Trading's INmune Bio position peaked at $334K in Q1 2025.
  • 82 funds tracked by Wall St. Rank held INmune Bio as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.